Article
Author(s):
Top news of the week from Specialty Pharmacy Times.
5. Chronic Inflammation in Rheumatoid Arthritis Attributed to Hibernating Cells
Hibernating innate lymphoid cells allows inflammation to persist in rheumatoid arthritis. Read more…
4. FDA Accepts Supplemental Biologics License Application for Lymphoma Drug
Brentuximab vedotin under evaluation for the treatment of cutaneous T-cell lymphoma. Read more…
3. Novel Leukemia Drug Gets FDA Orphan Drug Designation
A first-in-class selective retinoic acid receptor alpha agonist is being tested in phase 2 clinical trials for acute myeloid leukemia and myelodysplastic syndrome. Read more…
2. Top 5 Highest Grossing Specialty Drugs of the Year
Drugs that treat autoimmune disorders and hepatitis C virus power specialty drug spending. Read more…
1. New Specialty Drug Indications of 2017
Treatments for hepatitis C, hemophilia, and cholesterol among specialty drugs approved for new indications this year. Read more…
FDA Approves Bimekizumab-Bkzx as Treatment for Hidradenitis Suppurativa
FDA Approves Revumenib for the Treatment of Relapsed or Refractory Acute Leukemia